What Happened?
San Mateo, CA-based Sagimet-Biosciences Appointed George Kemble as Chief Executive Officer
About the Company
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors.
About the Person
George Kemble is Chief Executive Officer at Sagimet Biosciences. Previously, George held various senior HR leadership roles in the industry.
Info Source
News
Short Profile